世界の注射用テルリプレシン市場2023年:企業・地域・タイプ・用途別分析

◆英語タイトル:Global Terlipressin for Injection Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

GlobalInfoResearchが発行した調査報告書(GIR23SM7991)◆商品コード:GIR23SM7991
◆発行会社(リサーチ会社):GlobalInfoResearch
◆発行日:2023年9月
◆ページ数:119
◆レポート形式:英語 / PDF
◆納品方法:Eメール(注文後2-3日)
◆調査対象地域:グローバル
◆産業分野:医薬品&ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥528,960見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD5,220 ⇒換算¥793,440見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥1,057,920見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

GlobalInfoResearchの最新の調査によると、世界の注射用テルリプレシンの市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx%の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界の注射用テルリプレシン市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、タイプ別、用途別に記載されています。

市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。

本レポートの主な目的は次のとおりです。
- 世界および主要国の市場機会の規模を決定するため
- 注射用テルリプレシンの成長可能性を評価するため
- 各製品および最終用途市場の将来の成長を予測するため
- 市場に影響を与える競争要因を評価するため

注射用テルリプレシン市場はタイプと用途によって区分されます。2018年~2029年において、量と金額の観点からタイプ別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

タイプ別セグメント
・塊状、粉末状

用途別セグメント
・内科、外科、集中治療室(ICU)

主要な市場プレーヤー
・Ferring Pharmaceuticals、Ranbaxy UK Ltd、TAJ LIFE SCIENCES、Mallinckrodt plc、EVER Pharma、Alliance Pharmaceuticals、Serum Institute of India Pvt. Ltd、Biovenice Criticure、Criticine Care、Integrated Laboratories Pvt Ltd、Hybio Pharmaceutical Co., Ltd、Fujian Mindong Rejuenation Pharmaceutical Co., Ltd、Hangzhou Ausia Biological Technology Company, Ltd、Nanjing Kangzhou Pharmaceutical Technology Co., Ltd、Hainan General Sanyang Pharmaceutical Co., Ltd

地域別セグメントは次の地域・国をカバーします。
・北米(米国、カナダ、メキシコ)
・ヨーロッパ(ドイツ、フランス、イギリス、ロシア、イタリア)
・アジア太平洋(日本、中国、韓国、インド、東南アジア、オーストラリア)
・南アメリカ(ブラジル、アルゼンチン、コロンビア)
・中東およびアフリカ(サウジアラビア、UAE、エジプト、南アフリカ)

本調査レポートの内容は計15章あります。
・第1章では、注射用テルリプレシン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な注射用テルリプレシンメーカーの企業概要、2019年~2022年までの注射用テルリプレシンの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な注射用テルリプレシンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年~2029年までの地域別注射用テルリプレシンの販売量、売上、成長性を示しています。
・第5、6章では、2018年~2029年までの注射用テルリプレシンのタイプ別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年~2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年~2029年までの主要地域での注射用テルリプレシン市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、および注射用テルリプレシンの産業チェーンを掲載しています。
・第14、15章では、注射用テルリプレシンの販売チャネル、販売業者、顧客、調査結果について説明します。

・市場概要
– 注射用テルリプレシンの概要
– タイプ別分析(2018年vs2022年vs2029年):塊状、粉末状
– 用途別分析(2018年vs2022年vs2029年):内科、外科、集中治療室(ICU)
– 世界の注射用テルリプレシン市場規模・予測
– 世界の注射用テルリプレシン生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報(企業概要、製品概要、販売量、価格、売上)
– Ferring Pharmaceuticals、Ranbaxy UK Ltd、TAJ LIFE SCIENCES、Mallinckrodt plc、EVER Pharma、Alliance Pharmaceuticals、Serum Institute of India Pvt. Ltd、Biovenice Criticure、Criticine Care、Integrated Laboratories Pvt Ltd、Hybio Pharmaceutical Co., Ltd、Fujian Mindong Rejuenation Pharmaceutical Co., Ltd、Hangzhou Ausia Biological Technology Company, Ltd、Nanjing Kangzhou Pharmaceutical Technology Co., Ltd、Hainan General Sanyang Pharmaceutical Co., Ltd
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・タイプ別分析2018年-2029年:塊状、粉末状
・用途別分析2018年-2029年:内科、外科、集中治療室(ICU)
・注射用テルリプレシンの北米市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模:アメリカ、カナダ、メキシコなど
・注射用テルリプレシンのヨーロッパ市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模:ドイツ、イギリス、フランス、ロシア、イタリアなど
・注射用テルリプレシンのアジア市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模:中国、日本、韓国、インド、東南アジア、オーストラリアなど
・注射用テルリプレシンの南米市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模:ブラジル、アルゼンチンなど
・注射用テルリプレシンの中東・アフリカ市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模:サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学(成長要因、阻害要因、トレンド、ポーターズファイブフォース分析)
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

❖ レポートの目次 ❖

1 Market Overview
1.1 Product Overview and Scope of Terlipressin for Injection
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Terlipressin for Injection Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Lumps
1.3.3 Powder
1.4 Market Analysis by Application
1.4.1 Overview: Global Terlipressin for Injection Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Internal Medicine Application
1.4.3 surgical application
1.4.4 Intensive Care Unit (ICU) Applications
1.5 Global Terlipressin for Injection Market Size & Forecast
1.5.1 Global Terlipressin for Injection Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Terlipressin for Injection Sales Quantity (2018-2029)
1.5.3 Global Terlipressin for Injection Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Ferring Pharmaceuticals
2.1.1 Ferring Pharmaceuticals Details
2.1.2 Ferring Pharmaceuticals Major Business
2.1.3 Ferring Pharmaceuticals Terlipressin for Injection Product and Services
2.1.4 Ferring Pharmaceuticals Terlipressin for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Ferring Pharmaceuticals Recent Developments/Updates
2.2 Ranbaxy UK Ltd
2.2.1 Ranbaxy UK Ltd Details
2.2.2 Ranbaxy UK Ltd Major Business
2.2.3 Ranbaxy UK Ltd Terlipressin for Injection Product and Services
2.2.4 Ranbaxy UK Ltd Terlipressin for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Ranbaxy UK Ltd Recent Developments/Updates
2.3 TAJ LIFE SCIENCES
2.3.1 TAJ LIFE SCIENCES Details
2.3.2 TAJ LIFE SCIENCES Major Business
2.3.3 TAJ LIFE SCIENCES Terlipressin for Injection Product and Services
2.3.4 TAJ LIFE SCIENCES Terlipressin for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 TAJ LIFE SCIENCES Recent Developments/Updates
2.4 Mallinckrodt plc
2.4.1 Mallinckrodt plc Details
2.4.2 Mallinckrodt plc Major Business
2.4.3 Mallinckrodt plc Terlipressin for Injection Product and Services
2.4.4 Mallinckrodt plc Terlipressin for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Mallinckrodt plc Recent Developments/Updates
2.5 EVER Pharma
2.5.1 EVER Pharma Details
2.5.2 EVER Pharma Major Business
2.5.3 EVER Pharma Terlipressin for Injection Product and Services
2.5.4 EVER Pharma Terlipressin for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 EVER Pharma Recent Developments/Updates
2.6 Alliance Pharmaceuticals
2.6.1 Alliance Pharmaceuticals Details
2.6.2 Alliance Pharmaceuticals Major Business
2.6.3 Alliance Pharmaceuticals Terlipressin for Injection Product and Services
2.6.4 Alliance Pharmaceuticals Terlipressin for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Alliance Pharmaceuticals Recent Developments/Updates
2.7 Serum Institute of India Pvt. Ltd
2.7.1 Serum Institute of India Pvt. Ltd Details
2.7.2 Serum Institute of India Pvt. Ltd Major Business
2.7.3 Serum Institute of India Pvt. Ltd Terlipressin for Injection Product and Services
2.7.4 Serum Institute of India Pvt. Ltd Terlipressin for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Serum Institute of India Pvt. Ltd Recent Developments/Updates
2.8 Biovenice Criticure
2.8.1 Biovenice Criticure Details
2.8.2 Biovenice Criticure Major Business
2.8.3 Biovenice Criticure Terlipressin for Injection Product and Services
2.8.4 Biovenice Criticure Terlipressin for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Biovenice Criticure Recent Developments/Updates
2.9 Criticine Care
2.9.1 Criticine Care Details
2.9.2 Criticine Care Major Business
2.9.3 Criticine Care Terlipressin for Injection Product and Services
2.9.4 Criticine Care Terlipressin for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Criticine Care Recent Developments/Updates
2.10 Integrated Laboratories Pvt Ltd
2.10.1 Integrated Laboratories Pvt Ltd Details
2.10.2 Integrated Laboratories Pvt Ltd Major Business
2.10.3 Integrated Laboratories Pvt Ltd Terlipressin for Injection Product and Services
2.10.4 Integrated Laboratories Pvt Ltd Terlipressin for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Integrated Laboratories Pvt Ltd Recent Developments/Updates
2.11 Hybio Pharmaceutical Co., Ltd
2.11.1 Hybio Pharmaceutical Co., Ltd Details
2.11.2 Hybio Pharmaceutical Co., Ltd Major Business
2.11.3 Hybio Pharmaceutical Co., Ltd Terlipressin for Injection Product and Services
2.11.4 Hybio Pharmaceutical Co., Ltd Terlipressin for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Hybio Pharmaceutical Co., Ltd Recent Developments/Updates
2.12 Fujian Mindong Rejuenation Pharmaceutical Co., Ltd
2.12.1 Fujian Mindong Rejuenation Pharmaceutical Co., Ltd Details
2.12.2 Fujian Mindong Rejuenation Pharmaceutical Co., Ltd Major Business
2.12.3 Fujian Mindong Rejuenation Pharmaceutical Co., Ltd Terlipressin for Injection Product and Services
2.12.4 Fujian Mindong Rejuenation Pharmaceutical Co., Ltd Terlipressin for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Fujian Mindong Rejuenation Pharmaceutical Co., Ltd Recent Developments/Updates
2.13 Hangzhou Ausia Biological Technology Company, Ltd
2.13.1 Hangzhou Ausia Biological Technology Company, Ltd Details
2.13.2 Hangzhou Ausia Biological Technology Company, Ltd Major Business
2.13.3 Hangzhou Ausia Biological Technology Company, Ltd Terlipressin for Injection Product and Services
2.13.4 Hangzhou Ausia Biological Technology Company, Ltd Terlipressin for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Hangzhou Ausia Biological Technology Company, Ltd Recent Developments/Updates
2.14 Nanjing Kangzhou Pharmaceutical Technology Co., Ltd
2.14.1 Nanjing Kangzhou Pharmaceutical Technology Co., Ltd Details
2.14.2 Nanjing Kangzhou Pharmaceutical Technology Co., Ltd Major Business
2.14.3 Nanjing Kangzhou Pharmaceutical Technology Co., Ltd Terlipressin for Injection Product and Services
2.14.4 Nanjing Kangzhou Pharmaceutical Technology Co., Ltd Terlipressin for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Nanjing Kangzhou Pharmaceutical Technology Co., Ltd Recent Developments/Updates
2.15 Hainan General Sanyang Pharmaceutical Co., Ltd
2.15.1 Hainan General Sanyang Pharmaceutical Co., Ltd Details
2.15.2 Hainan General Sanyang Pharmaceutical Co., Ltd Major Business
2.15.3 Hainan General Sanyang Pharmaceutical Co., Ltd Terlipressin for Injection Product and Services
2.15.4 Hainan General Sanyang Pharmaceutical Co., Ltd Terlipressin for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Hainan General Sanyang Pharmaceutical Co., Ltd Recent Developments/Updates
3 Competitive Environment: Terlipressin for Injection by Manufacturer
3.1 Global Terlipressin for Injection Sales Quantity by Manufacturer (2018-2023)
3.2 Global Terlipressin for Injection Revenue by Manufacturer (2018-2023)
3.3 Global Terlipressin for Injection Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Terlipressin for Injection by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Terlipressin for Injection Manufacturer Market Share in 2022
3.4.2 Top 6 Terlipressin for Injection Manufacturer Market Share in 2022
3.5 Terlipressin for Injection Market: Overall Company Footprint Analysis
3.5.1 Terlipressin for Injection Market: Region Footprint
3.5.2 Terlipressin for Injection Market: Company Product Type Footprint
3.5.3 Terlipressin for Injection Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Terlipressin for Injection Market Size by Region
4.1.1 Global Terlipressin for Injection Sales Quantity by Region (2018-2029)
4.1.2 Global Terlipressin for Injection Consumption Value by Region (2018-2029)
4.1.3 Global Terlipressin for Injection Average Price by Region (2018-2029)
4.2 North America Terlipressin for Injection Consumption Value (2018-2029)
4.3 Europe Terlipressin for Injection Consumption Value (2018-2029)
4.4 Asia-Pacific Terlipressin for Injection Consumption Value (2018-2029)
4.5 South America Terlipressin for Injection Consumption Value (2018-2029)
4.6 Middle East and Africa Terlipressin for Injection Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Terlipressin for Injection Sales Quantity by Type (2018-2029)
5.2 Global Terlipressin for Injection Consumption Value by Type (2018-2029)
5.3 Global Terlipressin for Injection Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Terlipressin for Injection Sales Quantity by Application (2018-2029)
6.2 Global Terlipressin for Injection Consumption Value by Application (2018-2029)
6.3 Global Terlipressin for Injection Average Price by Application (2018-2029)
7 North America
7.1 North America Terlipressin for Injection Sales Quantity by Type (2018-2029)
7.2 North America Terlipressin for Injection Sales Quantity by Application (2018-2029)
7.3 North America Terlipressin for Injection Market Size by Country
7.3.1 North America Terlipressin for Injection Sales Quantity by Country (2018-2029)
7.3.2 North America Terlipressin for Injection Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Terlipressin for Injection Sales Quantity by Type (2018-2029)
8.2 Europe Terlipressin for Injection Sales Quantity by Application (2018-2029)
8.3 Europe Terlipressin for Injection Market Size by Country
8.3.1 Europe Terlipressin for Injection Sales Quantity by Country (2018-2029)
8.3.2 Europe Terlipressin for Injection Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Terlipressin for Injection Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Terlipressin for Injection Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Terlipressin for Injection Market Size by Region
9.3.1 Asia-Pacific Terlipressin for Injection Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Terlipressin for Injection Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Terlipressin for Injection Sales Quantity by Type (2018-2029)
10.2 South America Terlipressin for Injection Sales Quantity by Application (2018-2029)
10.3 South America Terlipressin for Injection Market Size by Country
10.3.1 South America Terlipressin for Injection Sales Quantity by Country (2018-2029)
10.3.2 South America Terlipressin for Injection Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Terlipressin for Injection Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Terlipressin for Injection Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Terlipressin for Injection Market Size by Country
11.3.1 Middle East & Africa Terlipressin for Injection Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Terlipressin for Injection Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Terlipressin for Injection Market Drivers
12.2 Terlipressin for Injection Market Restraints
12.3 Terlipressin for Injection Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Terlipressin for Injection and Key Manufacturers
13.2 Manufacturing Costs Percentage of Terlipressin for Injection
13.3 Terlipressin for Injection Production Process
13.4 Terlipressin for Injection Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Terlipressin for Injection Typical Distributors
14.3 Terlipressin for Injection Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

List of Tables
Table 1. Global Terlipressin for Injection Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Terlipressin for Injection Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Ferring Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 4. Ferring Pharmaceuticals Major Business
Table 5. Ferring Pharmaceuticals Terlipressin for Injection Product and Services
Table 6. Ferring Pharmaceuticals Terlipressin for Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Ferring Pharmaceuticals Recent Developments/Updates
Table 8. Ranbaxy UK Ltd Basic Information, Manufacturing Base and Competitors
Table 9. Ranbaxy UK Ltd Major Business
Table 10. Ranbaxy UK Ltd Terlipressin for Injection Product and Services
Table 11. Ranbaxy UK Ltd Terlipressin for Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Ranbaxy UK Ltd Recent Developments/Updates
Table 13. TAJ LIFE SCIENCES Basic Information, Manufacturing Base and Competitors
Table 14. TAJ LIFE SCIENCES Major Business
Table 15. TAJ LIFE SCIENCES Terlipressin for Injection Product and Services
Table 16. TAJ LIFE SCIENCES Terlipressin for Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. TAJ LIFE SCIENCES Recent Developments/Updates
Table 18. Mallinckrodt plc Basic Information, Manufacturing Base and Competitors
Table 19. Mallinckrodt plc Major Business
Table 20. Mallinckrodt plc Terlipressin for Injection Product and Services
Table 21. Mallinckrodt plc Terlipressin for Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Mallinckrodt plc Recent Developments/Updates
Table 23. EVER Pharma Basic Information, Manufacturing Base and Competitors
Table 24. EVER Pharma Major Business
Table 25. EVER Pharma Terlipressin for Injection Product and Services
Table 26. EVER Pharma Terlipressin for Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. EVER Pharma Recent Developments/Updates
Table 28. Alliance Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 29. Alliance Pharmaceuticals Major Business
Table 30. Alliance Pharmaceuticals Terlipressin for Injection Product and Services
Table 31. Alliance Pharmaceuticals Terlipressin for Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Alliance Pharmaceuticals Recent Developments/Updates
Table 33. Serum Institute of India Pvt. Ltd Basic Information, Manufacturing Base and Competitors
Table 34. Serum Institute of India Pvt. Ltd Major Business
Table 35. Serum Institute of India Pvt. Ltd Terlipressin for Injection Product and Services
Table 36. Serum Institute of India Pvt. Ltd Terlipressin for Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Serum Institute of India Pvt. Ltd Recent Developments/Updates
Table 38. Biovenice Criticure Basic Information, Manufacturing Base and Competitors
Table 39. Biovenice Criticure Major Business
Table 40. Biovenice Criticure Terlipressin for Injection Product and Services
Table 41. Biovenice Criticure Terlipressin for Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Biovenice Criticure Recent Developments/Updates
Table 43. Criticine Care Basic Information, Manufacturing Base and Competitors
Table 44. Criticine Care Major Business
Table 45. Criticine Care Terlipressin for Injection Product and Services
Table 46. Criticine Care Terlipressin for Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Criticine Care Recent Developments/Updates
Table 48. Integrated Laboratories Pvt Ltd Basic Information, Manufacturing Base and Competitors
Table 49. Integrated Laboratories Pvt Ltd Major Business
Table 50. Integrated Laboratories Pvt Ltd Terlipressin for Injection Product and Services
Table 51. Integrated Laboratories Pvt Ltd Terlipressin for Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Integrated Laboratories Pvt Ltd Recent Developments/Updates
Table 53. Hybio Pharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 54. Hybio Pharmaceutical Co., Ltd Major Business
Table 55. Hybio Pharmaceutical Co., Ltd Terlipressin for Injection Product and Services
Table 56. Hybio Pharmaceutical Co., Ltd Terlipressin for Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Hybio Pharmaceutical Co., Ltd Recent Developments/Updates
Table 58. Fujian Mindong Rejuenation Pharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 59. Fujian Mindong Rejuenation Pharmaceutical Co., Ltd Major Business
Table 60. Fujian Mindong Rejuenation Pharmaceutical Co., Ltd Terlipressin for Injection Product and Services
Table 61. Fujian Mindong Rejuenation Pharmaceutical Co., Ltd Terlipressin for Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Fujian Mindong Rejuenation Pharmaceutical Co., Ltd Recent Developments/Updates
Table 63. Hangzhou Ausia Biological Technology Company, Ltd Basic Information, Manufacturing Base and Competitors
Table 64. Hangzhou Ausia Biological Technology Company, Ltd Major Business
Table 65. Hangzhou Ausia Biological Technology Company, Ltd Terlipressin for Injection Product and Services
Table 66. Hangzhou Ausia Biological Technology Company, Ltd Terlipressin for Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Hangzhou Ausia Biological Technology Company, Ltd Recent Developments/Updates
Table 68. Nanjing Kangzhou Pharmaceutical Technology Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 69. Nanjing Kangzhou Pharmaceutical Technology Co., Ltd Major Business
Table 70. Nanjing Kangzhou Pharmaceutical Technology Co., Ltd Terlipressin for Injection Product and Services
Table 71. Nanjing Kangzhou Pharmaceutical Technology Co., Ltd Terlipressin for Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Nanjing Kangzhou Pharmaceutical Technology Co., Ltd Recent Developments/Updates
Table 73. Hainan General Sanyang Pharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 74. Hainan General Sanyang Pharmaceutical Co., Ltd Major Business
Table 75. Hainan General Sanyang Pharmaceutical Co., Ltd Terlipressin for Injection Product and Services
Table 76. Hainan General Sanyang Pharmaceutical Co., Ltd Terlipressin for Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Hainan General Sanyang Pharmaceutical Co., Ltd Recent Developments/Updates
Table 78. Global Terlipressin for Injection Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 79. Global Terlipressin for Injection Revenue by Manufacturer (2018-2023) & (USD Million)
Table 80. Global Terlipressin for Injection Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 81. Market Position of Manufacturers in Terlipressin for Injection, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 82. Head Office and Terlipressin for Injection Production Site of Key Manufacturer
Table 83. Terlipressin for Injection Market: Company Product Type Footprint
Table 84. Terlipressin for Injection Market: Company Product Application Footprint
Table 85. Terlipressin for Injection New Market Entrants and Barriers to Market Entry
Table 86. Terlipressin for Injection Mergers, Acquisition, Agreements, and Collaborations
Table 87. Global Terlipressin for Injection Sales Quantity by Region (2018-2023) & (K Units)
Table 88. Global Terlipressin for Injection Sales Quantity by Region (2024-2029) & (K Units)
Table 89. Global Terlipressin for Injection Consumption Value by Region (2018-2023) & (USD Million)
Table 90. Global Terlipressin for Injection Consumption Value by Region (2024-2029) & (USD Million)
Table 91. Global Terlipressin for Injection Average Price by Region (2018-2023) & (US$/Unit)
Table 92. Global Terlipressin for Injection Average Price by Region (2024-2029) & (US$/Unit)
Table 93. Global Terlipressin for Injection Sales Quantity by Type (2018-2023) & (K Units)
Table 94. Global Terlipressin for Injection Sales Quantity by Type (2024-2029) & (K Units)
Table 95. Global Terlipressin for Injection Consumption Value by Type (2018-2023) & (USD Million)
Table 96. Global Terlipressin for Injection Consumption Value by Type (2024-2029) & (USD Million)
Table 97. Global Terlipressin for Injection Average Price by Type (2018-2023) & (US$/Unit)
Table 98. Global Terlipressin for Injection Average Price by Type (2024-2029) & (US$/Unit)
Table 99. Global Terlipressin for Injection Sales Quantity by Application (2018-2023) & (K Units)
Table 100. Global Terlipressin for Injection Sales Quantity by Application (2024-2029) & (K Units)
Table 101. Global Terlipressin for Injection Consumption Value by Application (2018-2023) & (USD Million)
Table 102. Global Terlipressin for Injection Consumption Value by Application (2024-2029) & (USD Million)
Table 103. Global Terlipressin for Injection Average Price by Application (2018-2023) & (US$/Unit)
Table 104. Global Terlipressin for Injection Average Price by Application (2024-2029) & (US$/Unit)
Table 105. North America Terlipressin for Injection Sales Quantity by Type (2018-2023) & (K Units)
Table 106. North America Terlipressin for Injection Sales Quantity by Type (2024-2029) & (K Units)
Table 107. North America Terlipressin for Injection Sales Quantity by Application (2018-2023) & (K Units)
Table 108. North America Terlipressin for Injection Sales Quantity by Application (2024-2029) & (K Units)
Table 109. North America Terlipressin for Injection Sales Quantity by Country (2018-2023) & (K Units)
Table 110. North America Terlipressin for Injection Sales Quantity by Country (2024-2029) & (K Units)
Table 111. North America Terlipressin for Injection Consumption Value by Country (2018-2023) & (USD Million)
Table 112. North America Terlipressin for Injection Consumption Value by Country (2024-2029) & (USD Million)
Table 113. Europe Terlipressin for Injection Sales Quantity by Type (2018-2023) & (K Units)
Table 114. Europe Terlipressin for Injection Sales Quantity by Type (2024-2029) & (K Units)
Table 115. Europe Terlipressin for Injection Sales Quantity by Application (2018-2023) & (K Units)
Table 116. Europe Terlipressin for Injection Sales Quantity by Application (2024-2029) & (K Units)
Table 117. Europe Terlipressin for Injection Sales Quantity by Country (2018-2023) & (K Units)
Table 118. Europe Terlipressin for Injection Sales Quantity by Country (2024-2029) & (K Units)
Table 119. Europe Terlipressin for Injection Consumption Value by Country (2018-2023) & (USD Million)
Table 120. Europe Terlipressin for Injection Consumption Value by Country (2024-2029) & (USD Million)
Table 121. Asia-Pacific Terlipressin for Injection Sales Quantity by Type (2018-2023) & (K Units)
Table 122. Asia-Pacific Terlipressin for Injection Sales Quantity by Type (2024-2029) & (K Units)
Table 123. Asia-Pacific Terlipressin for Injection Sales Quantity by Application (2018-2023) & (K Units)
Table 124. Asia-Pacific Terlipressin for Injection Sales Quantity by Application (2024-2029) & (K Units)
Table 125. Asia-Pacific Terlipressin for Injection Sales Quantity by Region (2018-2023) & (K Units)
Table 126. Asia-Pacific Terlipressin for Injection Sales Quantity by Region (2024-2029) & (K Units)
Table 127. Asia-Pacific Terlipressin for Injection Consumption Value by Region (2018-2023) & (USD Million)
Table 128. Asia-Pacific Terlipressin for Injection Consumption Value by Region (2024-2029) & (USD Million)
Table 129. South America Terlipressin for Injection Sales Quantity by Type (2018-2023) & (K Units)
Table 130. South America Terlipressin for Injection Sales Quantity by Type (2024-2029) & (K Units)
Table 131. South America Terlipressin for Injection Sales Quantity by Application (2018-2023) & (K Units)
Table 132. South America Terlipressin for Injection Sales Quantity by Application (2024-2029) & (K Units)
Table 133. South America Terlipressin for Injection Sales Quantity by Country (2018-2023) & (K Units)
Table 134. South America Terlipressin for Injection Sales Quantity by Country (2024-2029) & (K Units)
Table 135. South America Terlipressin for Injection Consumption Value by Country (2018-2023) & (USD Million)
Table 136. South America Terlipressin for Injection Consumption Value by Country (2024-2029) & (USD Million)
Table 137. Middle East & Africa Terlipressin for Injection Sales Quantity by Type (2018-2023) & (K Units)
Table 138. Middle East & Africa Terlipressin for Injection Sales Quantity by Type (2024-2029) & (K Units)
Table 139. Middle East & Africa Terlipressin for Injection Sales Quantity by Application (2018-2023) & (K Units)
Table 140. Middle East & Africa Terlipressin for Injection Sales Quantity by Application (2024-2029) & (K Units)
Table 141. Middle East & Africa Terlipressin for Injection Sales Quantity by Region (2018-2023) & (K Units)
Table 142. Middle East & Africa Terlipressin for Injection Sales Quantity by Region (2024-2029) & (K Units)
Table 143. Middle East & Africa Terlipressin for Injection Consumption Value by Region (2018-2023) & (USD Million)
Table 144. Middle East & Africa Terlipressin for Injection Consumption Value by Region (2024-2029) & (USD Million)
Table 145. Terlipressin for Injection Raw Material
Table 146. Key Manufacturers of Terlipressin for Injection Raw Materials
Table 147. Terlipressin for Injection Typical Distributors
Table 148. Terlipressin for Injection Typical Customers
List of Figures
Figure 1. Terlipressin for Injection Picture
Figure 2. Global Terlipressin for Injection Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Terlipressin for Injection Consumption Value Market Share by Type in 2022
Figure 4. Lumps Examples
Figure 5. Powder Examples
Figure 6. Global Terlipressin for Injection Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Terlipressin for Injection Consumption Value Market Share by Application in 2022
Figure 8. Internal Medicine Application Examples
Figure 9. surgical application Examples
Figure 10. Intensive Care Unit (ICU) Applications Examples
Figure 11. Global Terlipressin for Injection Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Terlipressin for Injection Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Terlipressin for Injection Sales Quantity (2018-2029) & (K Units)
Figure 14. Global Terlipressin for Injection Average Price (2018-2029) & (US$/Unit)
Figure 15. Global Terlipressin for Injection Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Terlipressin for Injection Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Terlipressin for Injection by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Terlipressin for Injection Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Terlipressin for Injection Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Terlipressin for Injection Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Terlipressin for Injection Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Terlipressin for Injection Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Terlipressin for Injection Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Terlipressin for Injection Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Terlipressin for Injection Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Terlipressin for Injection Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Terlipressin for Injection Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Terlipressin for Injection Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Terlipressin for Injection Average Price by Type (2018-2029) & (US$/Unit)
Figure 30. Global Terlipressin for Injection Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Terlipressin for Injection Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Terlipressin for Injection Average Price by Application (2018-2029) & (US$/Unit)
Figure 33. North America Terlipressin for Injection Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Terlipressin for Injection Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Terlipressin for Injection Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Terlipressin for Injection Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Terlipressin for Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Terlipressin for Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Terlipressin for Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Terlipressin for Injection Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Terlipressin for Injection Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Terlipressin for Injection Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Terlipressin for Injection Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Terlipressin for Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Terlipressin for Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Terlipressin for Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Terlipressin for Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Terlipressin for Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Terlipressin for Injection Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Terlipressin for Injection Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Terlipressin for Injection Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Terlipressin for Injection Consumption Value Market Share by Region (2018-2029)
Figure 53. China Terlipressin for Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Terlipressin for Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Terlipressin for Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Terlipressin for Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Terlipressin for Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Terlipressin for Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Terlipressin for Injection Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Terlipressin for Injection Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Terlipressin for Injection Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Terlipressin for Injection Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Terlipressin for Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Terlipressin for Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Terlipressin for Injection Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Terlipressin for Injection Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Terlipressin for Injection Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Terlipressin for Injection Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Terlipressin for Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Terlipressin for Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Terlipressin for Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Terlipressin for Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Terlipressin for Injection Market Drivers
Figure 74. Terlipressin for Injection Market Restraints
Figure 75. Terlipressin for Injection Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Terlipressin for Injection in 2022
Figure 78. Manufacturing Process Analysis of Terlipressin for Injection
Figure 79. Terlipressin for Injection Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の注射用テルリプレシン市場2023年:企業・地域・タイプ・用途別分析(Global Terlipressin for Injection Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆